Bell Investment Advisors, Inc Ptc Therapeutics, Inc. Transaction History

Bell Investment Advisors, Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 08, 2023	SELL	$33.53 - $54.79 $335 - $547	-10 Reduced 35.71%	18 $0
Q3 2022 Nov 09, 2022	BUY	$41.85 - $53.85 $418 - $538	10 Added 55.56%	28 $1,000
Q2 2022 Aug 12, 2022	SELL	$25.6 - $45.23 $614 - $1,085	-24 Reduced 57.14%	18 $1,000
Q4 2021 Feb 14, 2022	SELL	$35.36 - $41.86 $813 - $962	-23 Reduced 35.38%	42 $2,000
Q3 2021 Nov 12, 2021	BUY	$37.01 - $44.74 $2,405 - $2,908	65 New	65 $2,000

221

78.1M

144K

58.7K

Ticker PTCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,541,000
Market Cap $3.31B
Description
PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...

Get notified when there are updates to the investment portfolio of Bell Investment Advisors, Inc, based on Form 13F filings with the SEC.

Stay updated on Bell Investment Advisors, Inc with notifications on news.